|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/506 | |
| C12Q 1/68 |
| (11) | Number of the document | 1909795 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06772756.0 |
| Date of filing the European patent application | 2006-06-09 | |
| (97) | Date of publication of the European application | 2008-04-16 |
| (45) | Date of publication and mention of the grant of the patent | 2011-04-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2006/022564 |
| Date | 2006-06-09 |
| (87) | Number | WO 2006/135790 |
| Date | 2006-12-21 |
| (30) | Number | Date | Country code |
| 689113 P | 2005-06-09 | US | |
| 736668 P | 2005-11-15 | US | |
| 748418 P | 2005-12-08 | US |
| (72) |
LEE, Francis, Y., US
HEINRICH, Michael, C., US
|
| (73) |
Bristol-Myers Squibb Company,
Lawrenceville-Princeton Road, Princeton NJ 08543-4000,
US
The United States of America, as Represented by the Department of Veterans Affairs, 810 Vermont Avenue, NW, Washington, D.C. 20420, US Oregon Health and Science University, 2525 SW First Avenue, Suite 120, Mail code AD120, Portland, Oregon 97201, US |
| (54) | PHARMACEUTICAL COMPOSITION FOR USE IN TREATING INDIVIDUALS EXHIBITING MUTANT KIT PROTEIN |
| PHARMACEUTICAL COMPOSITION FOR USE IN TREATING INDIVIDUALS EXHIBITING MUTANT KIT PROTEIN |